Logo image of CHSN

CHANSON INTERNATIONAL HOLD-A (CHSN) Stock Fundamental Analysis

NASDAQ:CHSN - Nasdaq - KYG2104U1076 - Common Stock - Currency: USD

0.129  0 (-0.39%)

After market: 0.1325 +0 (+2.71%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CHSN. CHSN was compared to 40 industry peers in the Consumer Staples Distribution & Retail industry. While CHSN seems to be doing ok healthwise, there are quite some concerns on its profitability. CHSN is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year CHSN was profitable.
CHSN had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CHSN reported negative net income in multiple years.
Of the past 5 years CHSN 4 years had a positive operating cash flow.
CHSN Yearly Net Income VS EBIT VS OCF VS FCFCHSN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 2M -2M

1.2 Ratios

Looking at the Return On Assets, with a value of 1.79%, CHSN is in line with its industry, outperforming 42.50% of the companies in the same industry.
CHSN has a Return On Equity of 4.17%. This is comparable to the rest of the industry: CHSN outperforms 42.50% of its industry peers.
Industry RankSector Rank
ROA 1.79%
ROE 4.17%
ROIC N/A
ROA(3y)-0.94%
ROA(5y)-0.31%
ROE(3y)-34.95%
ROE(5y)-18.79%
ROIC(3y)N/A
ROIC(5y)N/A
CHSN Yearly ROA, ROE, ROICCHSN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

1.3 Margins

CHSN has a better Profit Margin (4.11%) than 90.00% of its industry peers.
CHSN's Profit Margin has declined in the last couple of years.
CHSN's Gross Margin of 39.47% is amongst the best of the industry. CHSN outperforms 90.00% of its industry peers.
CHSN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 4.11%
GM 39.47%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y6.29%
PM growth 5Y-11.2%
GM growth 3Y-5.77%
GM growth 5Y-5.73%
CHSN Yearly Profit, Operating, Gross MarginsCHSN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 40

5

2. Health

2.1 Basic Checks

CHSN does not have a ROIC to compare to the WACC, probably because it is not profitable.
CHSN has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CHSN has been increased compared to 5 years ago.
The debt/assets ratio for CHSN has been reduced compared to a year ago.
CHSN Yearly Shares OutstandingCHSN Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
CHSN Yearly Total Debt VS Total AssetsCHSN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

CHSN has an Altman-Z score of 0.63. This is a bad value and indicates that CHSN is not financially healthy and even has some risk of bankruptcy.
CHSN's Altman-Z score of 0.63 is on the low side compared to the rest of the industry. CHSN is outperformed by 90.00% of its industry peers.
The Debt to FCF ratio of CHSN is 0.51, which is an excellent value as it means it would take CHSN, only 0.51 years of fcf income to pay off all of its debts.
CHSN's Debt to FCF ratio of 0.51 is amongst the best of the industry. CHSN outperforms 95.00% of its industry peers.
A Debt/Equity ratio of 0.08 indicates that CHSN is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.08, CHSN is doing good in the industry, outperforming 80.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.51
Altman-Z 0.63
ROIC/WACCN/A
WACC6.74%
CHSN Yearly LT Debt VS Equity VS FCFCHSN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

2.3 Liquidity

A Current Ratio of 1.29 indicates that CHSN should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.29, CHSN is doing good in the industry, outperforming 72.50% of the companies in the same industry.
CHSN has a Quick Ratio of 1.23. This is a normal value and indicates that CHSN is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Quick ratio value of 1.23, CHSN belongs to the best of the industry, outperforming 82.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 1.23
CHSN Yearly Current Assets VS Current LiabilitesCHSN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2

3. Growth

3.1 Past

CHSN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 300.00%, which is quite impressive.
The Earnings Per Share has been decreasing by -8.97% on average over the past years.
CHSN shows a small growth in Revenue. In the last year, the Revenue has grown by 5.65%.
The Revenue has been growing slightly by 7.70% on average over the past years.
EPS 1Y (TTM)300%
EPS 3Y7.72%
EPS 5Y-8.97%
EPS Q2Q%300%
Revenue 1Y (TTM)5.65%
Revenue growth 3Y7.46%
Revenue growth 5Y7.7%
Sales Q2Q%26.58%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHSN Yearly Revenue VS EstimatesCHSN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 3.23, which indicates a rather cheap valuation of CHSN.
CHSN's Price/Earnings ratio is rather cheap when compared to the industry. CHSN is cheaper than 97.50% of the companies in the same industry.
CHSN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.21.
Industry RankSector Rank
PE 3.23
Fwd PE N/A
CHSN Price Earnings VS Forward Price EarningsCHSN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, CHSN is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 1.19
EV/EBITDA -29.54
CHSN Per share dataCHSN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CHSN!.
Industry RankSector Rank
Dividend Yield N/A

CHANSON INTERNATIONAL HOLD-A

NASDAQ:CHSN (7/1/2025, 9:36:43 PM)

After market: 0.1325 +0 (+2.71%)

0.129

0 (-0.39%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners2.29%
Inst Owner ChangeN/A
Ins Owners33.96%
Ins Owner ChangeN/A
Market Cap3.52M
AnalystsN/A
Price TargetN/A
Short Float %22.81%
Short Ratio1
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 3.23
Fwd PE N/A
P/S 0.19
P/FCF 1.19
P/OCF 0.99
P/B 0.19
P/tB 0.19
EV/EBITDA -29.54
EPS(TTM)0.04
EY31.01%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.11
FCFY84.05%
OCF(TTM)0.13
OCFY100.52%
SpS0.67
BVpS0.7
TBVpS0.69
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.79%
ROE 4.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 4.11%
GM 39.47%
FCFM 16.24%
ROA(3y)-0.94%
ROA(5y)-0.31%
ROE(3y)-34.95%
ROE(5y)-18.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y6.29%
PM growth 5Y-11.2%
GM growth 3Y-5.77%
GM growth 5Y-5.73%
F-Score6
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.51
Debt/EBITDA 5.21
Cap/Depr 70.73%
Cap/Sales 3.18%
Interest Coverage N/A
Cash Conversion 1220.69%
Profit Quality 394.67%
Current Ratio 1.29
Quick Ratio 1.23
Altman-Z 0.63
F-Score6
WACC6.74%
ROIC/WACCN/A
Cap/Depr(3y)101.48%
Cap/Depr(5y)151.04%
Cap/Sales(3y)5%
Cap/Sales(5y)6.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)300%
EPS 3Y7.72%
EPS 5Y-8.97%
EPS Q2Q%300%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.65%
Revenue growth 3Y7.46%
Revenue growth 5Y7.7%
Sales Q2Q%26.58%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y13.11%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y176.49%
FCF growth 3YN/A
FCF growth 5Y30.24%
OCF growth 1Y220%
OCF growth 3Y25.76%
OCF growth 5Y19.88%